Metody metabolomiczne jako nowe narzedzie diagnostyki przewlekłej obturacyjnej choroby płuc

Translated title of the contribution: Application of metabolomic in COPD diagnosing

Piotr Młynarz, Wojciech Barg, Stanisław Deja, Renata Jankowska

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) is very heterogeneous, with multiple phenotypes and hardly predictable clinical course. There are no clearly defined biomarkers measuring its progress and advancement. In the recent years, development of modern measurement techniques, first of all the nuclear magnetic resonance and mass spectrometry, allowed their widespread use in biological research. These techniques can analyze tens to several thousands of fine chemicals. Together with chemometric analysis create new diagnostic tool - metabolomics, which evaluates the biochemical processes in biological systems with an assessment of metabolome (the set of all metabolites - small molecules compounds MW < 1000 Da found in the biological material). This in turn makes possible to monitor the quantitative and qualitative changes in activity of the body's metabolism at the cellular level. Theoretically, this may allow to detect disturbances of homeostasis before the onset of clinical symptoms and yet measurable laboratory changes. The results, of the studies so far relatively few, studies with the use of metabolomic methods in COPD suggest that it might be possible to differentiate COPD from other diseases, as well as diagnosing patients with COPD, including disease stratification and severity. It is necessary to conduct further research in order to assess the sensitivity and specificity of these methods in COPD.

Original languagePolish
Pages (from-to)207-212
Number of pages6
JournalPolski Merkuriusz Lekarski
Volume33
Issue number196
StatePublished - Oct 1 2012
Externally publishedYes

Fingerprint

Metabolomics
Chronic Obstructive Pulmonary Disease
Biochemical Phenomena
Metabolome
Research
Mass Spectrometry
Homeostasis
Magnetic Resonance Spectroscopy
Biomarkers
Phenotype
Sensitivity and Specificity

Keywords

  • Chronic obstructive pulmonary disease (COPD)
  • Metabolomisc
  • Spectrometry
  • Spectroscopy nuclear magnetic resonance (NMR)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Metody metabolomiczne jako nowe narzedzie diagnostyki przewlekłej obturacyjnej choroby płuc. / Młynarz, Piotr; Barg, Wojciech; Deja, Stanisław; Jankowska, Renata.

In: Polski Merkuriusz Lekarski, Vol. 33, No. 196, 01.10.2012, p. 207-212.

Research output: Contribution to journalReview article

Młynarz, Piotr ; Barg, Wojciech ; Deja, Stanisław ; Jankowska, Renata. / Metody metabolomiczne jako nowe narzedzie diagnostyki przewlekłej obturacyjnej choroby płuc. In: Polski Merkuriusz Lekarski. 2012 ; Vol. 33, No. 196. pp. 207-212.
@article{3586b3136f80458eaf77192d06c60e29,
title = "Metody metabolomiczne jako nowe narzedzie diagnostyki przewlekłej obturacyjnej choroby płuc",
abstract = "Chronic obstructive pulmonary disease (COPD) is very heterogeneous, with multiple phenotypes and hardly predictable clinical course. There are no clearly defined biomarkers measuring its progress and advancement. In the recent years, development of modern measurement techniques, first of all the nuclear magnetic resonance and mass spectrometry, allowed their widespread use in biological research. These techniques can analyze tens to several thousands of fine chemicals. Together with chemometric analysis create new diagnostic tool - metabolomics, which evaluates the biochemical processes in biological systems with an assessment of metabolome (the set of all metabolites - small molecules compounds MW < 1000 Da found in the biological material). This in turn makes possible to monitor the quantitative and qualitative changes in activity of the body's metabolism at the cellular level. Theoretically, this may allow to detect disturbances of homeostasis before the onset of clinical symptoms and yet measurable laboratory changes. The results, of the studies so far relatively few, studies with the use of metabolomic methods in COPD suggest that it might be possible to differentiate COPD from other diseases, as well as diagnosing patients with COPD, including disease stratification and severity. It is necessary to conduct further research in order to assess the sensitivity and specificity of these methods in COPD.",
keywords = "Chronic obstructive pulmonary disease (COPD), Metabolomisc, Spectrometry, Spectroscopy nuclear magnetic resonance (NMR)",
author = "Piotr Młynarz and Wojciech Barg and Stanisław Deja and Renata Jankowska",
year = "2012",
month = "10",
day = "1",
language = "Polish",
volume = "33",
pages = "207--212",
journal = "Polski Merkuriusz Lekarski",
issn = "1426-9686",
publisher = "MedPress",
number = "196",

}

TY - JOUR

T1 - Metody metabolomiczne jako nowe narzedzie diagnostyki przewlekłej obturacyjnej choroby płuc

AU - Młynarz, Piotr

AU - Barg, Wojciech

AU - Deja, Stanisław

AU - Jankowska, Renata

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Chronic obstructive pulmonary disease (COPD) is very heterogeneous, with multiple phenotypes and hardly predictable clinical course. There are no clearly defined biomarkers measuring its progress and advancement. In the recent years, development of modern measurement techniques, first of all the nuclear magnetic resonance and mass spectrometry, allowed their widespread use in biological research. These techniques can analyze tens to several thousands of fine chemicals. Together with chemometric analysis create new diagnostic tool - metabolomics, which evaluates the biochemical processes in biological systems with an assessment of metabolome (the set of all metabolites - small molecules compounds MW < 1000 Da found in the biological material). This in turn makes possible to monitor the quantitative and qualitative changes in activity of the body's metabolism at the cellular level. Theoretically, this may allow to detect disturbances of homeostasis before the onset of clinical symptoms and yet measurable laboratory changes. The results, of the studies so far relatively few, studies with the use of metabolomic methods in COPD suggest that it might be possible to differentiate COPD from other diseases, as well as diagnosing patients with COPD, including disease stratification and severity. It is necessary to conduct further research in order to assess the sensitivity and specificity of these methods in COPD.

AB - Chronic obstructive pulmonary disease (COPD) is very heterogeneous, with multiple phenotypes and hardly predictable clinical course. There are no clearly defined biomarkers measuring its progress and advancement. In the recent years, development of modern measurement techniques, first of all the nuclear magnetic resonance and mass spectrometry, allowed their widespread use in biological research. These techniques can analyze tens to several thousands of fine chemicals. Together with chemometric analysis create new diagnostic tool - metabolomics, which evaluates the biochemical processes in biological systems with an assessment of metabolome (the set of all metabolites - small molecules compounds MW < 1000 Da found in the biological material). This in turn makes possible to monitor the quantitative and qualitative changes in activity of the body's metabolism at the cellular level. Theoretically, this may allow to detect disturbances of homeostasis before the onset of clinical symptoms and yet measurable laboratory changes. The results, of the studies so far relatively few, studies with the use of metabolomic methods in COPD suggest that it might be possible to differentiate COPD from other diseases, as well as diagnosing patients with COPD, including disease stratification and severity. It is necessary to conduct further research in order to assess the sensitivity and specificity of these methods in COPD.

KW - Chronic obstructive pulmonary disease (COPD)

KW - Metabolomisc

KW - Spectrometry

KW - Spectroscopy nuclear magnetic resonance (NMR)

UR - http://www.scopus.com/inward/record.url?scp=84872681874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872681874&partnerID=8YFLogxK

M3 - Review article

C2 - 23272608

AN - SCOPUS:84872681874

VL - 33

SP - 207

EP - 212

JO - Polski Merkuriusz Lekarski

JF - Polski Merkuriusz Lekarski

SN - 1426-9686

IS - 196

ER -